Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Adma Biologics (ADMA) Inventory Average (2017 - 2025)

Adma Biologics' Inventory Average history spans 12 years, with the latest figure at $201.6 million for Q4 2025.

  • For Q4 2025, Inventory Average rose 17.86% year-over-year to $201.6 million; the TTM value through Dec 2025 reached $201.6 million, up 17.86%, while the annual FY2025 figure was $188.4 million, 9.78% up from the prior year.
  • Inventory Average reached $201.6 million in Q4 2025 per ADMA's latest filing, up from $194.1 million in the prior quarter.
  • In the past five years, Inventory Average ranged from a high of $201.6 million in Q4 2025 to a low of $87.8 million in Q1 2021.
  • Average Inventory Average over 5 years is $155.5 million, with a median of $163.4 million recorded in 2022.
  • Peak YoY movement for Inventory Average: surged 66.75% in 2021, then fell 2.34% in 2025.
  • A 5-year view of Inventory Average shows it stood at $119.4 million in 2021, then soared by 36.57% to $163.1 million in 2022, then grew by 3.01% to $168.0 million in 2023, then rose by 1.79% to $171.0 million in 2024, then grew by 17.86% to $201.6 million in 2025.
  • Per Business Quant, the three most recent readings for ADMA's Inventory Average are $201.6 million (Q4 2025), $194.1 million (Q3 2025), and $181.8 million (Q2 2025).